Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Birkenhäger W. H., Krauss X. H., Schalekamp M. A., Kolsters G., Kroon B. J. Antihypertensive effects of propranolol. Observations on predictability. Folia Med Neerl. 1971;14(2):67–71. [PubMed] [Google Scholar]
- Bravo E. L., Tarazi R. C., Dustan H. P. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. N Engl J Med. 1975 Jan 9;292(2):66–70. doi: 10.1056/NEJM197501092920203. [DOI] [PubMed] [Google Scholar]
- Bühler F. R., Laragh J. H., Baer L., Vaughan E. D., Jr, Brunner H. R. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med. 1972 Dec 14;287(24):1209–1214. doi: 10.1056/NEJM197212142872401. [DOI] [PubMed] [Google Scholar]
- Castenfors J., Johnsson H., Orö L. Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. Acta Med Scand. 1973 Mar;193(3):189–195. doi: 10.1111/j.0954-6820.1973.tb10560.x. [DOI] [PubMed] [Google Scholar]
- Davies R., Slater J. D., Rudolf M., Geddes D. M. The effect of isoprenaline on plasma renin activity in man: a dose-response curve. Clin Endocrinol (Oxf) 1977 May;6(5):395–399. doi: 10.1111/j.1365-2265.1977.tb02026.x. [DOI] [PubMed] [Google Scholar]
- Fitzgerald J. D. Beta-blockade and mechanisms of disease. Postgrad Med J. 1976;52 (Suppl 4):184–190. [PubMed] [Google Scholar]
- Frohlich E. D., Tarazi R. C., Dustan H. P., Page I. H. The paradox of beta-adrenergic blockade in hypertension. Circulation. 1968 Mar;37(3):417–423. doi: 10.1161/01.cir.37.3.417. [DOI] [PubMed] [Google Scholar]
- Hansson L., Zweifler A. J. The effct of propranolol on plasma renin activity and blood pressure in mild essential hypertension. Acta Med Scand. 1974 May;195(5):397–401. doi: 10.1111/j.0954-6820.1974.tb08159.x. [DOI] [PubMed] [Google Scholar]
- Hollifield J. W., Sherman K., Zwagg R. V., Shand D. G. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. N Engl J Med. 1976 Jul 8;295(2):68–73. doi: 10.1056/NEJM197607082950203. [DOI] [PubMed] [Google Scholar]
- LeWinter M. M., Crawford M. H., Karliner J. S., ORourke R. A. Effects of oral propranolol in normal subjects. Clin Pharmacol Ther. 1975 Jun;17(6):709–712. doi: 10.1002/cpt1975176709. [DOI] [PubMed] [Google Scholar]
- Leonetti G., Mayer G., Morganti A., Terzoli L., Zanchetti A., Bianchetti G., Di Salle E., Morselli P. L., Chidsey C. A. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl. 1975 Jun;48(6):491–499. doi: 10.1042/cs0480491. [DOI] [PubMed] [Google Scholar]
- Michelakis A. M., McAllister R. G. The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J Clin Endocrinol Metab. 1972 Feb;34(2):386–394. doi: 10.1210/jcem-34-2-386. [DOI] [PubMed] [Google Scholar]
- Miller R. R., Olson H. G., Pratt C. M., Amsterdam E. Z., Mason D. T. Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):598–605. doi: 10.1002/cpt1975185part1598. [DOI] [PubMed] [Google Scholar]
- Myers M. G., Lewis P. J., Reid J. L., Dollery C. T. Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther. 1975 Feb;192(2):327–335. [PubMed] [Google Scholar]
- Offerhaus L., van Zwieten P. A. Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers. Cardiovasc Res. 1974 Jul;8(4):488–495. doi: 10.1093/cvr/8.4.488. [DOI] [PubMed] [Google Scholar]
- Prichard B. N. Propranolol as an antihypertensive agent. Am Heart J. 1970 Jan;79(1):128–133. doi: 10.1016/0002-8703(70)90403-5. [DOI] [PubMed] [Google Scholar]
- Prichard B. N., Shinebourne E., Fleming J., Hamer J. Haemodynamic studies in hypertensive patients treated by oral proranolol. Br Heart J. 1970 Mar;32(2):236–240. doi: 10.1136/hrt.32.2.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sannerstedt R., Julius S., Conway J. Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation. 1970 Dec;42(6):1057–1064. doi: 10.1161/01.cir.42.6.1057. [DOI] [PubMed] [Google Scholar]
- Sealey J. E., Laragh J. H. Radioimmunoassay of plasma renin activity. Semin Nucl Med. 1975 Apr;5(2):189–202. doi: 10.1016/s0001-2998(75)80033-x. [DOI] [PubMed] [Google Scholar]
- Stokes G. S., Weber M. A., Thornell I. R. Beta-blockers and plasma renin activity in hypertension. Br Med J. 1974 Jan 12;1(5897):60–62. doi: 10.1136/bmj.1.5897.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stumpe K. O., Kolloch R., Vetter H., Gramann W., Krück F., Ressel C., Higuchi M. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. Am J Med. 1976 May 31;60(6):853–865. doi: 10.1016/0002-9343(76)90905-0. [DOI] [PubMed] [Google Scholar]
- Tarazi R. C., Dustan H. P. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol. 1972 May;29(5):633–640. doi: 10.1016/0002-9149(72)90164-6. [DOI] [PubMed] [Google Scholar]
- Taylor S. H., Davidson C., Singleton W., Thadani U. Proceedings: Comparison of antihypertensive effectiveness of beta-adrenoceptor antagonists with different pharmacological properties. Br Heart J. 1976 Mar;38(3):313–313. [PubMed] [Google Scholar]
- Ulrych M., Franciosa J., Conway J. Comparison of a new beta adrenergic blocker (MK 950) and propranolol in man. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):232–238. doi: 10.1002/cpt1972132232. [DOI] [PubMed] [Google Scholar]
- Ulrych M., Frohlich E. D., Dustan H. P., Page I. H. Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation. 1968 Mar;37(3):411–416. doi: 10.1161/01.cir.37.3.411. [DOI] [PubMed] [Google Scholar]
